Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB06718ApprovedVet approvedSmall molecule
Stanozolol is an anabolic steroid used to manage hereditary angioedema. Stanozolol is derived from testosterone, and has been abused by several high profile professional athletes.
- Mechanism
- Curator reviewed
Stanozolol binds to androgen receptors, such as membrane bound receptor proteins LAGS and stanozolol-binding protein (STBP).
- Primary indication
- Stanozolol is a synthetic anabolic steroid with therapeutic uses in treating C1-inhibitor deficient hereditary angioedema.Curator reviewed · 1 structured indication
- Formula / weight
- C21H32N2O · 328.4916 g/mol (avg)
- Also known as
- Androstanazol · Androstanazole
- Code names
- NSC-43193 · WIN 14833
Resolves to
Clinical / RWD
Structure
InChIKey
LKAJKIOFIWVMDJ-IYRCEVNGSA-NSMILES[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC3=NNC=C3C[C@]12CTargets
What you can answer from here — as of June 19, 2021
2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
Which drugs share a target with Stanozolol, and which of those have an active Phase 3 trial?